NVAX — NOVAVAX INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1000694 ·
Last close
$9.33
Market Cap
$1.53B
52W High
$11.61
52W Low
$7.71
ADV30
4,647,086
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 139,514,000 | 108,819,000 | -15,430,000 | -9,491,000 | 1,043,162,000 | 228,363,000 | 1,187,924,000 |
| Dec 2025 | 147,139,000 | 125,035,000 | 15,037,000 | 17,527,000 | 1,176,512,000 | 240,634,000 | 1,304,265,000 |
| Sep 2025 | 70,445,000 | 48,949,000 | -80,980,000 | -202,379,000 | 1,179,889,000 | 268,023,000 | 1,336,561,000 |
| Jun 2025 | 239,240,000 | 223,915,000 | 101,070,000 | 106,508,000 | 1,336,549,000 | 253,744,000 | 1,298,924,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-244,635,000
Investing CF
$-78,267,000
Financing CF
$27,737,000
CapEx
$-6,388,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$2.41
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,568,148,000
Inventory
$11,545,000
Receivables
$106,446,000
ST Investments
$494,450,000
EBIT TTM
$464,714,000
Pretax Income TTM
$442,167,000
Interest Exp TTM
$22,547,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$596,337,984
EBITDA
$59,532,000
Free Cash Flow
$58,573,936
Enterprise Value
$1,050,444,288
Total Cash
$790,332,032
Total Debt
$295,057,984
Shares Out
164,438,119
Trailing EPS
$-0.56
Book Value
$-0.88
ROE
—
ROA
2.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,123,479,000 | 550,640,000 | 440,302,000 | 1,176,512,000 | 1,304,265,000 | — | -244,635,000 |
| Dec 2024 | 682,162,000 | -248,931,000 | -187,499,000 | 1,560,418,000 | 2,184,259,000 | — | -87,263,000 |
| Dec 2023 | 556,382,000 | -566,511,000 | -545,062,000 | 1,797,490,000 | 2,514,417,000 | — | -713,967,000 |
| Dec 2022 | 1,598,951,000 | -644,736,000 | -657,939,000 | 2,258,679,000 | 2,892,757,000 | — | -415,937,000 |
TTM Snapshot
Revenues TTM
$1,184,919,000
NetIncome TTM
$-743,120,000
OpCashFlow TTM
$0
Assets (Latest)
$1,560,418,000
Forward EPS
$-0.54
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMCR | Immunocore Holdings plc | $1.63B | $31.95 | — |
| VIR | Vir Biotechnology, Inc. | $1.68B | $9.96 | — |
| MAZE | Maze Therapeutics, Inc. | $1.69B | $30.57 | — |
| INBX | Inhibrx Biosciences, Inc. | $1.36B | $93.01 | — |
| COAG | Hemab Therapeutics Holdings, Inc. | $1.78B | $38.03 | — |
News headlines (Yahoo Finance, 1h cache)
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
2026-07-10 14:18 · Yahoo
Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?
2026-07-10 05:15 · Yahoo
Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters
2026-07-10 03:24 · Yahoo
TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know
2026-07-09 14:52 · Yahoo
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
2026-07-08 21:45 · Yahoo
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study
2026-07-07 14:10 · Yahoo
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
2026-07-07 13:00 · Yahoo
Novavax (NVAX) Stock Moves 1.36%: What You Should Know
2026-07-02 21:45 · Yahoo
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
2026-07-02 08:44 · Yahoo
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM
2026-06-24 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.